TMEM158 and central nervous system cancer: Furthermore, we assessed the expression of TMEM158 in eight different glioma cell lines, including A172, LN18, LN229, TJ905, T98G, SNB19, U251MG, and U87MG, using western blotting, among which TJ905 is a primary GBM cell line.